EpiCept Corporation announced that it has filed for Fast Track designation for AmiKet, their new topical cream to be used in the treatment of chemotherapy-induced peripheral neuropathy. The Fast Track program, created by the FDA, is designed to facilitate development and expedite review of drugs intended to treat serious or life-threatening conditions and address unmet …
EpiCept Files for AmiKet™ Fast Track Designation Read More »
In a study from the Colorado Cancer Center, results have shown that using Oxaliplatin for the treatment of colorectal cancer causes Oxaliplatin-induced neurotoxicity (OXIN). One way to avoid immediate symptoms from the drug is to use a ‘stop and go’ treatment cycle giving the drug with breaks in between treatments. The study was published in …
According to the results of a small pilot study published in Acupuncture in Medicine, acupuncture may help relieve the severe pain associated with chemotherapy-induced peripheral neuropathy. READ MORE Source: Medscape
Fighting ovarian cancer for over 12 years, Barbara McQuade of Ft. Myers, FL, developed neuropathy in her hands and feet. Neuropathy is common in cancer patients. To give patients some relief, Lee Memorial Health System added an acupuncturist to their staff. Being used to treat not just the neuropathy but the nausea, vomiting and dry …
Using Acupuncture for Side Effects of Chemotherapy Read More »
DARA BioSciences, recently awarded fast track designation from the FDA for the development of their new drug for the treatment of neuropathic pain, has just released the results of a Phase II safety and efficacy study. The study showed KRN5500 demonstrated a statistically significant improvement in the relief of neuropathic pain versus a placebo. READ …
Kaiser Health just release information about studies which indicate that rehabilitation for cancer patients, during and after chemotherapy treatments, are necessary to regain enough functionality to perform ordinary activities. One patient realized that after 6 weeks of therapies for peripheral neuropathy and balance issues, she “didn’t feel so limited by side effects any longer.” READ …
Cancer Patients Could Benefit from Greater Use of Rehabilitation Read More »
Researchers at University of Wisconsin Carbone Cancer Center are testing a new pain therapy device for patients with nerve pain following chemotherapy treatments. With 40 percent of chemotherapy patients developing neuropathy it is an important step in finding new, effective treatments. Forty patients will be part of the clinical trial. READ MORE Source: University of Wisconsin
Oxaliplatin has become the standard of care for people with advanced colorectal cancer. It appears to cause nerve damage that may be permanent and worsens even months after treatment ends. Dr. Michael Polydefkis, Johns Hopkins University School of Medicine professor and researcher, is leading a team to find ways of preventing or slowing the damage …
Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects for people with blood and bone marrow cancers. Faiman has worked as a nurse practitioner since 1994 at the Cleveland Clinic Taussig Cancer Center with patients diagnosed …
New Research has Potential to Alleviate Side Effects of Cancer Treatments Read More »
Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by the NIH to develop a new treatment for preventing nerve damage. “This is a case of ‘bench to bedside’ research,” Dr. Fink says. READ MORE …
U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage Read More »
